Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADVISORY/"Enabling Tomorrow's Medicines Today".


Business Editors & Health/Medical Writers

BIO 2002

BIOWIRE2K

ADVISORY...for Tuesday (June 11)

--(BW HealthWire)

Amersham Biosciences hosts press briefing at BIO 2002 Focusing on technologies that will speed up functional biology, disease research and drug discovery, development and manufacture


WHAT:                      David Weber, President, Region North
                           America, and Ger Brophy, Vice President,
                           Business Development for Bioassays, will
                           discuss the role that Amersham Biosciences'
                           innovative products, such as the IN Cell
                           Analyzer, will play in the drug discovery
                           process.

WHY:                       Amersham Biosciences' technologies are
                           enabling scientists and researchers to find
                           new drug targets and develop new
                           pharmaceuticals more quickly, thus helping
                           to make the dream of molecular medicine
                           a reality.

WHEN:                      Tuesday, June 11, 2002
                           3:00 p.m. - 4:00 p.m. EST

WHERE:                     Toronto Metropolitan Convention Center
                           255 Bremner Blvd. (alternate entrance)
                           South Building, Room 712
                           Toronto, Ontario
                           Room 712


About Amersham Biociences:

Amersham Biosciences, the life sciences business of Amersham plc Amersham plc was a UK pharmaceutical company, specializing in medical diagnostics and life science products.

The company was formed in 1997 by merging Amersham International (U.K.), Pharmacia Biotech (Sweden) and Nycomed (Norway).
 (LSE LSE - Language Sensitive Editor : NYSE NYSE

See: New York Stock Exchange
: OSE OSE - Open Systems Environment : AHM AHM Automated Hacking Machines
AHM All Hands Meeting
AHM Academy for Healthcare Management
AHM Atom Heart Mother (Pink Floyd album)
AHM Airport Handling Manual
AHM Acutely Hazardous Material
AHM Anti-Helicopter Mine
), is a world leader in developing and providing integrated systems and solutions for disease research, drug development, and manufacture. Our systems are used to uncover the function of genes and proteins, for the discovery and development of drugs, and for the manufacture of biopharmaceuticals. The customers for Amersham Biosciences' products and technology are pharmaceutical and biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
, and research and academic institutions, principally in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , Europe, Latin America, and Asia. More information about Amersham Biosciences is available at www.amershambiosciences.com
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 6, 2002
Words:239
Previous Article:Avrum Gray Joins Board of Directors of SL Industries, Inc.
Next Article:Thermal Reprices Some Old Stock Options, and Issues Some New Stock Options to Provide Renewed Incentive to Employees, Officers, Directors, and...
Topics:



Related Articles
NextMed -- The End Of Health Care?
HIGHLIGHTS AND LOWLIGHTS.
Lorus Therapeutics Presents Virulizin Results At International Chemotherapy Symposium.
Deborah Steelman Joins Eli Lilly and Company as Vice President, Corporate Affairs.
Lilly Commits Two Senior Officials To War On Terrorism.
Ionix Appoints Peter Fellner as Chairman.
Shared vision of college and real estate leaders.
Rhea & Kaiser Marketing Communications (R&K) hosts eight students for the third year.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles